INSIGHTS ON QUALITY ASSURANCE
-
![pharma-partners-GettyImages-2182052451]( "Why Emerging Drug Developers Can't Afford To Delay Analytical Development")
Why Emerging Drug Developers Can't Afford To Delay Analytical DevelopmentRushing early pharma development by neglecting quality and analytical frameworks risks regulatory failures, clinical holds, and expensive rework.
-
![Quality Time With Oliver Guest Michael Dominguez]( "Quality Time With Oliver: Guest Michael Dominguez")
Quality Time With Oliver: Guest Michael DominguezBuild a stronger CCIT strategy with practical guidance on risk assessment, method development, and validation, as well as how to improve collaboration between sponsors and testing laboratories.
-
![GettyImages-1087219142 Scientist Using Digital Tablet Computer In Manufacturing Laboratory]( "The Shift To GMP-Compliant Automation In CGT Manufacturing")
The Shift To GMP-Compliant Automation In CGT ManufacturingManual processes are yielding to automated, GMP-compliant closed systems in CGT manufacturing. This shift is crucial for meeting Annex 1 contamination standards and creating scalable, reliable commercial production.
-
![antibody molecules-GettyImages-2165626333]( "ADC Development Grows More Complex — SPR Insights Bring Clarity")
ADC Development Grows More Complex — SPR Insights Bring ClarityExplore how real-time kinetic analysis reveals how conjugation, linker chemistry, and drug loading influence antibody–antigen interactions, while enabling sensitive detection of anti-drug antibodies.
-
How AI-Enabled Validation Technologies Enable The Predictive Plant3/18/2026
Discover how AI-enabled digital validation shifts manufacturers from reactive compliance to predictive intelligence, connecting validation, asset, and quality data to accelerate digital maturity.
-
Ensuring Performance And Compliance: Successful FAT Of Filling Line Isolator For Creative Lifesciences, Taiwan3/19/2026
Rigorous Factory Acceptance Testing ensures filling line isolators meet performance and safety standards. This validation is vital for aseptic integrity and protecting both product and operator.
-
GMP Calibration Management8/8/2025
Learn why generic EAM systems fall short in regulated industries and how purpose-built solutions ensure compliance, efficiency, and audit readiness.
-
Your Guide To Precise And Robust Separation Methods11/12/2025
Discover a detailed guide to characterizing GLP-1 receptor agonists that covers advanced LC-MS and SEC-MALS workflows for impurity profiling, stability testing, and aggregate analysis.
-
A Scalable Analytical Method For Quality-Driven AAV Characterization7/1/2026
AEX-HPLC has emerged as a robust, GMP-compatible analytical method for accurately characterizing AAV capsid composition, enabling consistent assessment of empty, partial, and full capsids to support product quality, process development, and regulatory readiness.
QUALITY ASSURANCE SOLUTIONS
-
![GettyImages-2178829362 GLP-1]( "Advance Peptide Therapeutics And GLP-1 Receptor Agonists Faster")
Analyzing GLP-1 receptor agonist (RA) drugs has become increasingly complex. Peptide structures, closely-related impurities, and rising demands for sensitivity, speed, and compliance are putting pressure on laboratories.
-
![Rheofreed]( "A Game-Changing Innovation In Lyophilization Technology")
-
![Esco-Pharmcon Downflow Booth Gen 2 (DFBG2)]( "Customizable Downflow Booths")
Ensure operator safety and product purity with unidirectional airflow solutions. Explore how modular ISO 5 environments provide containment and cross-contamination control for critical processes.
-
![GettyImages-1327977866-cell-culture-sample-laboratory]( "Powering Production Of Viral Vector-Based Therapies")
Gene therapies hold immense potential to provide long-lasting treatments for a wide range of diseases. At Cytiva, we offer GMP-compliant, end-to-end manufacturing solutions designed to support the development and commercialization of advanced medicines across multiple modalities – including AAV, adenovirus (AV), lentivirus (LV), plasmid DNA (pDNA) and exosomes. Our dependable suite of technologies and expertise ensures scalability, quality, and regulatory confidence at every stage of your journey.
-
![LSC-Media-for-VV]( "HyClone™ Cell Culture Media For Viral Vector Production")
Whether you're looking to boost performance, enhance your capabilities, or simply get consistent, high-quality results, HyClone™ peak expression medium and HyClone™ prime expression medium are the solutions for you.
